Immunization; Infection Clinical Trial
Official title:
Use of SMS and Interactive Reminders to Improve Timely Immunization Coverage: A Randomized Controlled Trial
Pakistan has one of the highest infant mortality rates in the world. One child in eleven dies
before their fifth birthday. In part, this is due to the low coverage rate of routine
childhood immunizations. Since Pakistan is a Low Middle Income Country (LMIC) it is essential
that an immunization intervention be developed that is suitable for its socioeconomic
setting. The tele-density of Pakistan exceeds 70% and the cost of SMS in Pakistan is very
low. Moreover the use of SMS in the country has broadened beyond the conventional use of
peer-peer chat to include social networking, SMS banking, delivery tracking, advertising,
business, disaster management, and identity verification. This study will utilise this
prevalence of mobile phones to assess whether simple and interactive sms reminders can serve
to increase childhood immunization coverage and timeliness.
The pilot study will be carried out only in 2 EPI (Extended program on Immunization) centers
at Korangi. The pilot will determine whether automated text messages produce increased
immunization coverage in the reminder groups compared to the control group. 656 participants
will be enrolled at Penta-1 and will be followed up until measles-2 vaccination. The results
of proposed pilot will provide the basis for a large scale-up study in urban and rural
settings in Pakistan.
Hypothesis:
The coverage rate of Penta-3, Measles-1 and Measles-2 in infants in Karachi will improve
with:
1. Short text Messaging Service (SMS) reminders
2. Interactive reminders
Aims:
1. To determine if SMS reminders increases timely vaccine coverage rate in infants from
Karachi.
2. To determine if Interactive reminders increases the timely vaccine coverage rate in
infants from Karachi.
Background and Rationale:
The World Health Organization's (WHO) goal is to protect all people at risk against
vaccine-preventable diseases. The availability of vaccines, however, does not mean that all
eligible children are vaccinated. Despite several decades of global efforts in program
implementation, vaccine-preventable diseases still contribute 25% of the 10 million
deaths/year in under-5 children occurring worldwide. The Expanded Program on Immunization
(EPI) does provide wide-access to vaccines in developing countries, but low vaccine uptake
and delayed immunizations make infants and children more vulnerable to vaccine preventable
diseases. The result of suboptimal immunization rates is the persistent existence of several
vaccine preventable diseases. Many different strategies are being tested in these settings to
increase immunization coverage, including out-reach services, health education, information
dissemination, vaccination requirements for schools, conditional cash transfers and enhancing
access to vaccination centers. This study proposes to investigate the use of SMS and
interactive text reminders to improve timely immunization coverage. SMS reminders have the
potential to increase immunization coverage and could prove to be a simple low cost
intervention to improve timely immunization coverage.
SMS reminders Although there is limited data, SMS has been successfully used in various
health programs including raising preventive and clinical treatment compliance, increasing
HIV testing,4 reducing missed primary care and dental visits etc. Kaewkungwal's study
designed a maternal and child care module based on SMS reminders and increased EPI on-time
vaccinations to 44% from 35% (p<0.001). Vilella's study showed 47% (95% Confidence Interval
(CI): 41-54%) of the participants in SMS reminder intervention arm completed third dose of
hepatitis A + B vaccine as compared to 27% (95% CI: 23-32%) in control arm (RR 1.75; 95% CI:
1.41-2.17). SMS reminders have shown a potential simple cost-effective solution to remember
the next vaccination date. With the growing use of mobile phones, SMS reminders can be quite
useful in health communications. The cost of SMS in Pakistan is very low and use of SMS has
broadened beyond the conventional use of peer-peer chat to include social networking, SMS
banking, delivery tracking, advertising, business, disaster management, and identity
verification etc. With such a low cost and varied use of SMS, it has a potential to be a
frequent mode of health communications.
Interactive reminders Interactive reminders are a variant of SMS reminders where recipients
are asked to respond back to SMS with a specific/non-specific response. Our experience of
pilot with interactive reminders to tuberculosis patients to comply with drug adherence has
shown positive acceptability. The system can be potentially used for compliance to vaccine
schedule. The pilot study will be carried out only in 2 EPI centers at Korangi. The pilot
will determine whether automated text messages produce increased immunization coverage in the
reminder groups compared to the control group over the 8 weeks follow-up. The results of
proposed pilot will provide the basis for a large scale-up study in urban and rural settings
in Pakistan.
Study site & Participants:
The study will be conducted in Korangi town, Karachi. Healthy infants 6-12 weeks of age
visiting the Indus Hospital EPI center for first dose of pentavalent vaccine will be
recruited for the study. Study will require parents/caregivers of infants to own a cell phone
or have regular access to one. Parents/caregivers planning to go to a different center for
next immunization will be excluded.
Sample size:
A sample of 522 participants would give 90% power (alpha= 0.05, 2-sided) to detect a
difference of 15% over the baseline vaccine coverage rate of 70%. The final sample size of
656 infants (164 in each arm) will allow for a potential dropout rate of 20% during the
follow-up period.
Randomization Enrolled subjects will be randomized to receive the SMS, interactive SMS or to
serve as a control. The randomization sequence was created using SAS, version 9.3 (SAS
Institute, Cary, NC), with a 1:1:1 allocation, using random block sizes of 3, 6, and 9.
Vaccines:
The vaccines will be administered as per routine EPI program in Pakistan which include
Bacille Calmette-Guérin (BCG) at 0-6 weeks of age, pentavalent (DPT + Hepatitis B (HepB) +
Hib) vaccine and oral polio vaccine at 6, 10 and 14 weeks of age, measles vaccine at 9 and 15
months of age.
Interventions:
The two interventions include SMS and interactive reminders. Infants will be randomized to
either of the interventions or control groups. All participants will receive the routine EPI
immunizations.
Study procedures & Recruitment:
Children will be recruited at the EPI center when they arrived for the Penta-1 vaccine. Field
workers will screen and obtain consent from the child's caregiver. Once the caregiver agrees
to be a part of the study the infant will be randomised to one of the study arms and the name
and age of the child will be recorded along with the immunization received on the visit. Each
infant will be provided with a unique EPI number by the EPI staff and the same identifier
(ID) will be used throughout the study to update and maintain the immunization record for all
follow up visits. The child will be followed up to the measles 2 vaccine after which their
immunization status will be marked as complete.
The parents of infants in SMS and interactive reminder groups will received 3-5 reminders for
all scheduled follow-up immunization visits until the measles 2 vaccine. The infants in the
control group will carry out routine follow up without any added intervention.
After the completion of follow-up duration a phone interview will be conducted to collect
data on experiences of study participants with the SMS and interactive reminders. This will
be a brief 3-5 minute interview to confirm if they received the messages and if there were
any suggestions to improve the reminder system.
Statistical Analysis An intention to treat analysis will be conducted using STATA'13. Summary
statistics and percentages will be calculated to establish coverage and timeliness rates
within the three study arms. Fisher's Exact test with an alpha of 0.05 will be conducted to
test differences in proportions for coverage and timelines
Additionally to determine factors associated with measles-2 completion at 24 months of age, a
bivariate analysis will be conducted.Variables previously examined for association with
measles 2 completion at 24 months via a bivariate analysis will then be selected for
determining final multivariate model. All the variables will first be used in the model and
the coefficients and the vif will be examined. Next, forward selection and step wise
selection will be carried out in STATA to determine final model for a logistic regression.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT03854630 -
Hepatitis B Virus Vaccination in HIV-positive Patients and Individuals at High Risk for HIV Infection
|
Phase 4 | |
Completed |
NCT04042246 -
Effect of Knowledge on Vaccine Take-up in Adamawa State, Northeastern Nigeria
|
N/A | |
Enrolling by invitation |
NCT05570630 -
VAX-MOM COVID-19: Increasing Maternal COVID-19 Vaccination
|
N/A | |
Completed |
NCT03145324 -
Immunisation History Survey - a Study to Measure Levels of Immunity to Routine Immunisations
|
||
Recruiting |
NCT06185647 -
Evaluation in Practice of the Impact of NIrsevimab on EmeRgency Use for BRONCHIOlitis
|
||
Recruiting |
NCT05215327 -
High vs. Standard Dose Influenza Vaccine in Lung Allograft Recipients
|
Phase 2 | |
Completed |
NCT03355989 -
Evaluation of Conditional Cash Transfers (CCTs) for Immunization
|
N/A | |
Completed |
NCT02992925 -
Phase 3 Study of BK1310 in Healthy Infants
|
Phase 3 | |
Completed |
NCT03121638 -
Safety Study of NBP608 in Healthy Adult Volunteers
|
Phase 1 | |
Not yet recruiting |
NCT05171946 -
Phase-I Study to Evaluate the Safety and Immunogenicity of a Prophylactic pDNA Vaccine Candidate Against COVID-19 in Healthy Adults
|
Phase 1 | |
Completed |
NCT05661890 -
Seasonal Influenza and Pneumococcal Vaccination in the Elderly
|
||
Active, not recruiting |
NCT04444518 -
Increasing Influenza and Tdap Vaccination of Pregnant Women
|
N/A | |
Active, not recruiting |
NCT03908164 -
Optimising the Timing of Whooping Cough Immunisation in MUMs
|
Phase 4 | |
Not yet recruiting |
NCT03402646 -
Mobile Phone Reminders (and Photovoice) for Routine Immunization in Nigeria - The MOPING Study
|
N/A | |
Completed |
NCT04824638 -
BNT162b2 Vaccination With 2 Doses in COVID-19 Negative Volunteers and With a Single Dose in COVID-19 Positive Volunteers
|
Phase 2 | |
Recruiting |
NCT05774093 -
Evaluation of COVID-19 Immune Barrier and Reinfection Risk
|
||
Completed |
NCT03083158 -
Immunity to Hepatitis B Vaccine
|
Phase 4 | |
Recruiting |
NCT04816760 -
Immune Cells Phenotypes During COVID-19
|
||
Completed |
NCT04870021 -
Hepatitis B Birth Dose for Newborns
|
Phase 4 | |
Completed |
NCT03519373 -
Pertussis Immunization During Pregnancy & HIV Infection
|